Fuzbien Technology Institute Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 1

Fuzbien Technology Institute General Information

Description

Developer of biosensors designed to detect biomarkers of breast cancer. The company's biosensors make early detection of biomarkers which is accurate and inexpensive, enabling patients to get the required treatment at an early stage.

Contact Information

Website
fuzbientech.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • 13 Taft Court
  • Suite 207
  • Rockville, MD 20850
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fuzbien Technology Institute Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 00000 Completed Generating Revenue
2. Early Stage VC 19-Jul-2011 0000 00000 Completed Generating Revenue
1. Accelerator/Incubator 04-Feb-2009 $222K $222K Completed Generating Revenue
To view Fuzbien Technology Institute’s complete valuation and funding history, request access »

Fuzbien Technology Institute Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fuzbien Technology Institute Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maryland Industrial Partnerships University 000 0000 000000 0
To view Fuzbien Technology Institute’s complete investors history, request access »